Cargando…
In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors
We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV‐I‐infected T‐cells using peripheral blood mononuclear cells (PBMC) of adult T‐cell leukemia (ATL) patients, asymptomatic HTLV‐I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeated...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920587/ https://www.ncbi.nlm.nih.gov/pubmed/7537726 http://dx.doi.org/10.1111/j.1349-7006.1995.tb02983.x |
_version_ | 1783317854844616704 |
---|---|
author | Katahira, Yoshihiko Yashiki, Shinji Fujiyoshi, Toshinobu Nomura, Kouichiro Tara, Mitsutoshi Mori, Miyuki Setoyama, Mitsuru Kanzaki, Tamotsu Shida, Hisatoshi Sonoda, Shunro |
author_facet | Katahira, Yoshihiko Yashiki, Shinji Fujiyoshi, Toshinobu Nomura, Kouichiro Tara, Mitsutoshi Mori, Miyuki Setoyama, Mitsuru Kanzaki, Tamotsu Shida, Hisatoshi Sonoda, Shunro |
author_sort | Katahira, Yoshihiko |
collection | PubMed |
description | We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV‐I‐infected T‐cells using peripheral blood mononuclear cells (PBMC) of adult T‐cell leukemia (ATL) patients, asymptomatic HTLV‐I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeatedly for 4 weeks with HLA‐matched HTLV‐I‐infected T‐cells which had been pretreated at 56deg;C for 30 min to inactivate infectious HTLV‐I. The culture medium included 10–100 units/ml of recombinant lymphokines (rIL‐1, rIL‐2, rIL‐4, rIL‐6 and rIL‐7) and 10% fetal calf serum in RPMI‐1640 medium. The cytotoxic activity was measured against HLA‐matched HTLV‐I‐infected T‐cell lines after CD4(+) or CD8(+) cells were positively panned from the cultured PBMC. The PBMC of ATL, AC and healthy donors were able to produce either CD4(+) or CD8(+) CTLs against HTLV‐I‐related antigens (env, gag, p21(x), p27(rex) and p40(tax)) as well as the antigen(s) of as‐yet unknown specificity expressed on HTLV‐I‐infected T‐cells. All the CTLs recognized the specific antigens in the context of either class I or class II HLA types. These results indicated that ATL patients, AC and healthy donors were immunocompetent to generate CTLs against HTLV‐I‐infected T‐cells and probably against HTLV‐I‐transformed T‐cells. |
format | Online Article Text |
id | pubmed-5920587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-59205872018-05-11 In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors Katahira, Yoshihiko Yashiki, Shinji Fujiyoshi, Toshinobu Nomura, Kouichiro Tara, Mitsutoshi Mori, Miyuki Setoyama, Mitsuru Kanzaki, Tamotsu Shida, Hisatoshi Sonoda, Shunro Jpn J Cancer Res Article We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV‐I‐infected T‐cells using peripheral blood mononuclear cells (PBMC) of adult T‐cell leukemia (ATL) patients, asymptomatic HTLV‐I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeatedly for 4 weeks with HLA‐matched HTLV‐I‐infected T‐cells which had been pretreated at 56deg;C for 30 min to inactivate infectious HTLV‐I. The culture medium included 10–100 units/ml of recombinant lymphokines (rIL‐1, rIL‐2, rIL‐4, rIL‐6 and rIL‐7) and 10% fetal calf serum in RPMI‐1640 medium. The cytotoxic activity was measured against HLA‐matched HTLV‐I‐infected T‐cell lines after CD4(+) or CD8(+) cells were positively panned from the cultured PBMC. The PBMC of ATL, AC and healthy donors were able to produce either CD4(+) or CD8(+) CTLs against HTLV‐I‐related antigens (env, gag, p21(x), p27(rex) and p40(tax)) as well as the antigen(s) of as‐yet unknown specificity expressed on HTLV‐I‐infected T‐cells. All the CTLs recognized the specific antigens in the context of either class I or class II HLA types. These results indicated that ATL patients, AC and healthy donors were immunocompetent to generate CTLs against HTLV‐I‐infected T‐cells and probably against HTLV‐I‐transformed T‐cells. Blackwell Publishing Ltd 1995-01 /pmc/articles/PMC5920587/ /pubmed/7537726 http://dx.doi.org/10.1111/j.1349-7006.1995.tb02983.x Text en |
spellingShingle | Article Katahira, Yoshihiko Yashiki, Shinji Fujiyoshi, Toshinobu Nomura, Kouichiro Tara, Mitsutoshi Mori, Miyuki Setoyama, Mitsuru Kanzaki, Tamotsu Shida, Hisatoshi Sonoda, Shunro In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title | In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title_full | In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title_fullStr | In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title_full_unstemmed | In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title_short | In vitro Induction of Cytotoxic T Lymphocytes against HTLV‐I‐infected T‐Cells from Adult T‐Cell Leukemia Patients, Asymptomatic HTLV‐I Carriers and Seronegative Healthy Donors |
title_sort | in vitro induction of cytotoxic t lymphocytes against htlv‐i‐infected t‐cells from adult t‐cell leukemia patients, asymptomatic htlv‐i carriers and seronegative healthy donors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920587/ https://www.ncbi.nlm.nih.gov/pubmed/7537726 http://dx.doi.org/10.1111/j.1349-7006.1995.tb02983.x |
work_keys_str_mv | AT katahirayoshihiko invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT yashikishinji invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT fujiyoshitoshinobu invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT nomurakouichiro invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT taramitsutoshi invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT morimiyuki invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT setoyamamitsuru invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT kanzakitamotsu invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT shidahisatoshi invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors AT sonodashunro invitroinductionofcytotoxictlymphocytesagainsthtlviinfectedtcellsfromadulttcellleukemiapatientsasymptomatichtlvicarriersandseronegativehealthydonors |